[García-Ferrer L, Bagán JV, Martínez-Sanjuan V, Hernandez-Bazan S, García R, Jiménez-Soriano Y, et al. MRI of mandibular osteonecrosis secondary to bisphosphonates. Am J Roentgenol 2008; 190: 949-55.10.2214/AJR.07.3045]Search in Google Scholar
[Horvat AG, Kovac V, Strojan P. Radiotherapy in palliative treatment of painful bone metastases. Radiol Oncol 2009; 43: 213-24.10.2478/v10019-009-0038-4]Search in Google Scholar
[Cheng A, Mavrokokki A, Carter G, Stein B, Fazzalari NL, Wilson DF, et al. The dental implications of bisphosphonates and bone disease. Aust Dent J 2005; 50: 4-13.10.1111/j.1834-7819.2005.tb00384.x]Search in Google Scholar
[Debevec L, Jeric T, Kovac V, Bitenc M, Sok M. Is there any progress in routine management of lung cancer patients? A comparative analysis of an institution in 1996 and 2006. Radiol Oncol 2009; 43: 47-53.10.2478/v10019-009-0008-x]Search in Google Scholar
[Rajer M, Kovac V. Malignant spinal cord compression. Radiol Oncol 2008; 42: 23-31.10.2478/v10019-007-0035-4]Search in Google Scholar
[Phal PM, Myall RW, Assael LA, Weissman JL. Imaging findings of bisphosphonate-associated osteonecrosis of the jaws. Am J Neuroradiol 2007; 28: 1139-45.10.3174/ajnr.A0518]Search in Google Scholar
[Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115-7.10.1016/S0278-2391(03)00720-1]Search in Google Scholar
[Migliorati CA. Bisphosphonate-associated oral osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 135.10.1016/j.tripleo.2004.10.00115660080]Search in Google Scholar
[Pogrel MA. Bisphosphonates and bone necrosis. J Oral Maxillofac Surg 2004; 62: 391-2.10.1016/j.joms.2003.11.00315015179]Search in Google Scholar
[Bisdas S, Chambron Pinho N, Smolarz A, Sader R, Vogl TJ, Mack MG. Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients. Clin Radiol 2008; 63: 71-7.10.1016/j.crad.2007.04.02318068792]Search in Google Scholar
[Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005; 63: 1567-75.10.1016/j.joms.2005.07.010]Search in Google Scholar
[Arce K, Assael LA, Weissman JL, Markiewicz MR. Imaging findings in bisphosphonate-related osteonecrosis of jaw. J Oral Maxillofac Surg 2009; 67: 75-84.10.1016/j.joms.2008.12.002]Search in Google Scholar
[Orlandini F, Bossard D, Blanc G, Bodard AG, Gourmet R. Osteonecrosis of the jaw and biphosphonates: imaging features. J Radiol 2009; 90: 199-205.10.1016/S0221-0363(09)72470-9]Search in Google Scholar
[Krishnan A, Arslanoglu A, Yildirm N, Silbergleit R, Aygun N. Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings. J Comput Assist Tomogr 2009; 33: 298-304.10.1097/RCT.0b013e31817e4986]Search in Google Scholar
[Elad S, Gomori MJ, Ben-Ami N, Friedlander-Barenboim S, Regev E, Lazarovici TS, et al. Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation. Clin Oral Investig 2010; 14: 43-50.10.1007/s00784-009-0311-3]Search in Google Scholar
[Allen MR, Burr DB. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 2009; 67: 61-70.10.1016/j.joms.2009.01.007]Search in Google Scholar
[Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, et al. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg 2009; 67: 1904-13.10.1016/j.joms.2009.04.05119686928]Search in Google Scholar
[Williamson RA. Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg 2010; 39: 251-5.10.1016/j.ijom.2009.11.014]Search in Google Scholar
[Migliorati CA, Siegel MA, Elting LS. Biphosphonate-associated osteonecrosis: a long term complication of biphosphonate treatment. Lancet Oncol 2006; 7: 508-14.10.1016/S1470-2045(06)70726-4]Search in Google Scholar
[Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update. J Oral Maxillofac Surg 2009; 67: 2-12.]Search in Google Scholar
[Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, et al. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg 2009; 67: 1904-13.10.1016/j.joms.2009.04.051]Search in Google Scholar
[Podobnik J, Kocijancic I, Kovac V, Sersa I. 3T MRI in evaluation of asbestosrelated thoracic diseases - preliminary results. Radiol Oncol 2010; 44: 92-6.10.2478/v10019-010-0027-7342368522933897]Search in Google Scholar
[Bedogni A, Blandamura S, Lokmic Z, Palumbo C, Ragazzo M, Ferrari F, et al. Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 358-64.10.1016/j.tripleo.2007.08.04018280968]Search in Google Scholar
[Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R. Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 2006; 35: 236-43.10.1259/dmfr/2745872616798918]Search in Google Scholar
[Naik NH, Russo TA. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces. Clin Infect Dis 2009; 49: 1729-32.10.1086/64807519886792]Search in Google Scholar
[Hansen T, Kunkel M, Springer E, Walter C, Weber A, Siegel E, et al. Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch 2007; 45: 1009-17.10.1007/s00428-007-0516-217952459]Search in Google Scholar